🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07679958
Starting soon Not applicable

Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular Therapy

NCT07679958 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-09-15
Last updated
2026-09-02

Condition(s) studied

Hematologic DiseasesHematopoietic Stem Cell TransplantationCellular TherapyQuality of LifeOncologic Disorders

Investigational drug(s) / intervention(s)

Intervention with IVRControl

Intervention with IVR: The RVI intervention program will consist of the following phases: * Phase 1: Exposure to introductory scenarios and use of the RVI software and hardware, adaptation to virtual environments, observation of passive scenarios aimed at emotional balance, and interactive scenarios involving general mobility and neuromuscular activation. Week 1. * Phase 2: Progression towards tasks that improve response times and attentional mechanisms. Starting in week 2. * Phase 3: More complex multicomponent physical exercise based on boxing techniques, movements of the upper limbs, trunk, head, and lower limbs, coordination exercises, and cyclical cardiovascular exercise.

Control: Intervention based on the standard treatment program of activities of routine clinical practice: Breathing exercises, resistance exercises with and without weights and aerobic exercises.

Study summary

Cell therapy (CT), including hematopoietic stem cell transplantation (HSCT) and advanced CAR T-cell therapies, is used for the treatment of oncohematological and other diseases. HSCT is associated with treatment-related toxicities, including fatigue, muscle weakness, and reduced functional capacity due to intensive conditioning chemotherapy, immunosuppressive treatments, corticosteroids, and complications such as infections or graft-versus-host disease. Emotional symptoms, including anxiety, depression, fear, and frustration, also affect patients' recovery and ability to regain functional independence. Evidence indicates that exercise interventions improve emotional well-being, fatigue, quality of life, physical function, cardiovascular fitness, and muscle mass in patients with hematological malignancies and HSCT recipients.

Virtual reality (VR) has emerged as an innovative tool in rehabilitation, supporting patient motivation, exercise guidance, and monitoring. Immersive virtual reality (IVR), through head-mounted displays and multisensory environments, enhances the sense of presence and engagement. Studies suggest that IVR-based exercise programs are feasible, improving functional abilities, quality of life, satisfaction, and adherence.

Since 2017, a Therapeutic Exercise program for patients admitted for HSCT has been implemented at Álvaro Cunqueiro Hospital (Vigo) through collaboration between the Physiotherapy Unit and the Hematology Department. Before admission, patients undergo a physical assessment, receive an individualized exercise plan, education, and a therapeutic exercise guide. Based on clinical experience, the team hypothesizes that integrating IVR into therapeutic exercise may improve motivation, adherence, and emotional well-being during hospitalization.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18 years or older. * Signed informed consent. * Patients eligible for CT scan at the Alvaro Cunqueiro Hospital. * Patients capable of performing therapeutic exercise independently, based on an objective initial functional assessment. * The clinical investigator, in their professional judgment, determines that the patient can adhere to all study requirements. Exclusion Criteria: * Patients under 18 years of age. * Any medical condition or mental illness that could interfere with understanding HIP and CI. * Patients participating in another clinical trial. * Balance disorders that increase the risk of falls. * Severe visual and/or auditory impairments that prevent participation in the session. * History of vertigo, seizures, or epileptic fits.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Álvaro Cunqueiro (Vigo) Vigo Pontevedra

More Fundacin Biomedica Galicia Sur trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07679958 on ClinicalTrials.gov ↗ ← All trials in Spain